Sexual Health Market, by Product Type (Erectile Dysfunction Drugs, Gender Dysphoria Drugs, Hypoactive Sexual Desire Disorder Drugs, Premature Ejaculation Drugs, and Others), by Gender (Male and Female), by Distribution Channel (Hospital Pharmacies, Retail

Sexual Health Market, by Product Type (Erectile Dysfunction Drugs, Gender Dysphoria Drugs, Hypoactive Sexual Desire Disorder Drugs, Premature Ejaculation Drugs, and Others), by Gender (Male and Female), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Sexual health is an important part of a person’s physical and mental health. Sexual health leads to the healthy sexual life without any sexual dysfunctions, and preventive measures to avoid sexually transmitted infections. The adult population largely suffers from one or more sexual disorders such as dyspareunia, erectile dysfunctions, hypoactive sexual desire disorder, premature (early) ejaculation, and others. According to National Center for Biotechnology Information 2016, sexual dysfunction is highly prevalent, and affects around 43% of women and 31% of men, globally. Currently, various treatment options such as medication, mechanical aids, sexual therapies, and others are available for treating such sexual dysfunctions and to improve sexual health of the person.
Market Dynamics
Increasing incidence and prevalence of sexual disorders is a major factor augmenting growth of the market. Some of the major factors which cause sexual dysfunction are aging population, stressful and unhealthy lifestyle, and other psychological parameters. According to a study published in the National Center for Biotechnology Information in April 2016, hypoactive sexual desire disorder (HSDD) is present in around 8.9% and 12.3% women in the age group of 18 - 44 years and 45 – 64 years, respectively.
Moreover, robust product development activities by major key players is engaged in the introduction of innovative and highly effective drug treatment for improving sexual health. For instance, in June 2019, AMAG Pharmaceuticals received the U.S. FDA approval for Vyleesi (bremelanotide) for treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. Thus, increasing approvals by regulatory authorities are expected to drive the growth of the sexual health market.
Key features of the study:
This report provides in-depth analysis of the global sexual health market, market size (US$ Mn), and compound annual growth rate (CAGR %) over the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new technology launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles leading players in the global sexual health market based on the following parameters – company overview, financial performance, technology portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Teva Pharmaceutical Industries Ltd., Meda Pharmaceuticals, Inc., Eli Lilly & Company, Bayer AG, Vivus, Inc., Zydus Pharmaceuticals, IVFTECH APS, Merck & Co., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Novartis International AG, Mylan Pharmaceuticals Inc., and AstraZeneca
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future technology launches, government initiatives, technological upgradation, market expansion, and marketing tactics
The global sexual health market report caters to various stakeholders in this market, including investors, technology manufacturers, distributors, and suppliers in the sexual health market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:
Global Sexual Health Market, By Product Type:
Erectile Dysfunction Drugs
Gender Dysphoria Drugs
Hypoactive Sexual Desire Disorder Drugs
Premature Ejaculation Drugs
Others
Global Sexual Health Market, By Gender:
Male
Female
Global Sexual Health Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Sexual Health Market, By Region:
North America
By Product Type:
Erectile Dysfunction Drugs
Gender Dysphoria Drugs
Hypoactive Sexual Desire Disorder Drugs
Premature Ejaculation Drugs
Others
By Gender:
Male
Female
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.S.
Canada
Europe
By Product Type:
Erectile Dysfunction Drugs
Gender Dysphoria Drugs
Hypoactive Sexual Desire Disorder Drugs
Premature Ejaculation Drugs
Others
By Gender:
Male
Female
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
By Product Type:
Erectile Dysfunction Drugs
Gender Dysphoria Drugs
Hypoactive Sexual Desire Disorder Drugs
Premature Ejaculation Drugs
Others
By Gender:
Male
Female
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
Latin America
By Product Type:
Erectile Dysfunction Drugs
Gender Dysphoria Drugs
Hypoactive Sexual Desire Disorder Drugs
Premature Ejaculation Drugs
Others
By Gender:
Male
Female
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
By Product Type:
Erectile Dysfunction Drugs
Gender Dysphoria Drugs
Hypoactive Sexual Desire Disorder Drugs
Premature Ejaculation Drugs
Others
By Gender:
Male
Female
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Erectile Dysfunction Drugs
Gender Dysphoria Drugs
Hypoactive Sexual Desire Disorder Drugs
Premature Ejaculation Drugs
Others
By Gender:
Male
Female
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Teva Pharmaceutical Industries Ltd.
Company Overview
Technology Portfolio
Financial Performance
Recent Highlights
Strategies
Meda Pharmaceuticals, Inc.
Eli Lilly & Company
Bayer AG
Vivus, Inc.
Zydus Pharmaceuticals
IVFTECH APS
Merck & Co.
Pfizer Inc.
Sun Pharmaceutical Industries Ltd
Novartis International AG
Mylan Pharmaceuticals Inc.
AstraZeneca
“*” marked represents similar segmentation in other categories in the respective section.